Revised bill of pharmaceutical affairs law to present to National Assembly at Oct. end.

Published: 1999-09-27 11:23:00

Updated: 1999-09-27 11:23:00

As the separation plan was finally determined in the 2nd meeting of the Drug Separation Execution Commission the MOHW plans to prepare a revised bill of the pharmaceutical affairs law legally to support the separation program so as to announce it in Oct., and then submit it to the National Assemb...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK